Cerulean Pharma (CERU) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts CERU Hot Sheet
Join SI Premium – FREE
Cerulean Pharma (NASDAQ: CERU) reported Q3 EPS of ($0.39), $0.02 better than the analyst estimate of ($0.41).
For earnings history and earnings-related data on Cerulean Pharma (CERU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- ACRES Commercial Realty says labor dispute is hindering hotel sale
- Deere shares climb as fiscal Q3 earnings and revenue top estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
